A Deep Dive into the Risks and Realities Download our GLP-1 app to Turn Your Weight Loss Journey into Your Favorite Game What is Tirzepatide Microdosing, and Can Lower Doses Be Effective
Secure online health assessment Review by an independent licensed provider Prescription when medically approved Compounded medication from a participating pharmacy Four weekly injections for a typical monthly program Injection supplies provided with the prescription Ongoing provider and care-team support Dose adjustments when clinically appropriate Free expedited medication shipping No additional charge based solely on a higher prescribed dose Program contents may vary by medication, pharmacy, treatment term and state availability
With a sulfonylurea (a type of diabetes pill that lowers blood sugar), SURPASS-4 (Del Prato et al., Lancet 2021) reported hypoglycemia below 54 mg/dL in roughly 10 to 14% of tirzepatide users on the combination (9.9% at 10 mg, 12.8% at 15 mg, 13.8% at 5 mg) over up to 104 weeks
Some of the most common or potential side effects include: Nausea Constipation Vomiting Diarrhea Abdominal Pain Headache Indigestion Injection Site Reactions Dizziness Back pain Increased Lipase or Amylase Altered Taste Nasopharyngitis (common cold) Passing Gas Bloating Belching Gastroenteritis Decreased Appetite Fatigue Gastroesophageal Reflux Disease Low Blood Sugar (hypoglycemia) in those with type II diabetes Upset Stomach These symptoms often subside as your body adjusts to the medications
doi: 10.1021/acs.jmedchem.5b00726
The dose in weekly tirzepatide injections is far below the amounts used in sleep studies, however